Results 171 to 180 of about 8,013 (194)

Clioquinol as a new therapy in epilepsy: From preclinical evidence to a proof-of-concept clinical study. [PDF]

open access: yesEpilepsia
Thevissen K   +25 more
europepmc   +1 more source

ZNF146 accelerates lung adenocarcinoma progression through MDM2/p53 and PHGDH/ferroptosis. [PDF]

open access: yesCell Biosci
Zhu J   +12 more
europepmc   +1 more source

Nutrient requirements of organ-specific metastasis in breast cancer. [PDF]

open access: yesNature
Abbott KL   +32 more
europepmc   +1 more source

Species-specific serine metabolism differentially controls natural killer cell functions. [PDF]

open access: yesNat Metab
Li JH   +14 more
europepmc   +1 more source

Metabolic reprogramming in bone metastasis of human cancers. [PDF]

open access: yesFront Cell Dev Biol
Li T, Wang Z, Yang H, Kang Y.
europepmc   +1 more source

Biophysical and biochemical properties of PHGDH revealed by studies on PHGDH inhibitors

Cellular and Molecular Life Sciences, 2021
The rate-limiting serine biogenesis enzyme PHGDH is overexpressed in cancers. Both serine withdrawal and genetic/pharmacological inhibition of PHGDH have demonstrated promising tumor-suppressing activities. However, the enzyme properties of PHGDH are not well understood and the discovery of PHGDH inhibitors is still in its infancy.
Yuping Tan   +8 more
openaire   +2 more sources

Abstract 3014: PHGDH- A therapeutic vulnerability in melanoma

Cancer Research, 2022
Abstract Recurrently amplified oncogenes may represent melanoma vulnerabilities that can be exploited for therapy. The genomic locus containing the Phosphoglycerate Dehydrogenase (PHGDH) gene at chromosome 1p12 is frequently amplified in melanoma.
Neel N. Jasani, Florian Karreth
openaire   +1 more source

Home - About - Disclaimer - Privacy